Skip to main content
SpringerLink
Log in

Molecular insights into TSH receptor abnormality and thyroid disease

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nagayama Y., Kaufman K.D., Seto P., Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 165: 1184, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Libert F., Lefort A., Gerard C., Parmentier M., Perret J., Ludgate M., Dumont J.E., Vassart G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun. 165: 1250, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Misrahi M., Loosfelt H., Atger M., Sar S., Guiochon-Mantel A., Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun. 166: 394, 1990.

    Article  PubMed  CAS  Google Scholar 

  4. Nagayama Y., Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol. Endocrinol. 6: 145, 1992.

    PubMed  CAS  Google Scholar 

  5. Vassart G., Parma J., Van Sande J., Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 13: 596, 1992.

    PubMed  CAS  Google Scholar 

  6. Laugwitz K.L., Allgeier A., Offermann S., Spicher K., Van Sande J., Dumont J.E., Schultz G. The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc. Natl. Acad. Sci. USA 93: 116, 1996.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Dumont J.E., Lamy F., Roger P., Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72: 667, 1992.

    PubMed  CAS  Google Scholar 

  8. Spiegel A.M. Defects in G Protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58: 143, 1995.

    Article  Google Scholar 

  9. Pearce S.H.S., Trump D. G-protein-coupled receptors in endocrine disease. Q. J. Med. 88: 3, 1995.

    CAS  Google Scholar 

  10. Nagayama Y., Wadsworth H.L., Chazenbalk G.D., Russo D., Seto P., Rapoport B. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for TSH receptor function. Proc. Natl. Acad. Sci. USA 88: 902, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Nagayama Y., Rapoport B. Role of carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Endocrinology 131: 548, 1992.

    PubMed  CAS  Google Scholar 

  12. Kosugi S., Mori T. TSH receptor and LH receptor, 1995. Endocr. J. 42: 587, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Chazenbalk G.D., Nagayama Y., Russo D., Wadsworth H.L., Rapoport B. Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J. Biol. Chem. 265: 20970, 1990.

    PubMed  CAS  Google Scholar 

  14. Chazenbalk G.D., Nagayama Y., Wadsworth H.L., Russo D., Rapoport B. Signal transduction by the human thyrotropin receptor: studies on the role of individual amino acid residues in the carboxyl terminal region of the third cytoplasmic loop. Mol. Endocrinol. 5: 1523, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Paschke R., Parmentier M., Vassart G. Importance of the extracellular domain of the human thyrotropin receptor for activation of cyclic AMP production. J. Mol. Endocrinol. 13: 199, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Robinson P.R., Cohen G.B., Zhukovsky E.A., Oprian D.D. Constitutively active mutants of Rhodopsin. Neuron 9: 719, 1992.

    Article  PubMed  CAS  Google Scholar 

  17. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rhefuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72: 827, 1993.

    Article  PubMed  CAS  Google Scholar 

  18. Allen L.F., Lefkowitz R.J., Caron M.G., Cotecchia S. G Protein coupled receptor genes as protooncogenes: constitutively activating mutation of the α1 B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc. Natl. Acad. Sci. USA 88: 11354, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  19. Samama P., Cotecchia S., Costa T., Lefkowitz R.J. A mutation induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268: 4625, 1993.

    PubMed  CAS  Google Scholar 

  20. Ledent C., Dumont J.E., Vassart G., Parmentier M. Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11: 537, 1992.

    PubMed Central  PubMed  CAS  Google Scholar 

  21. Gross B., Misrahi M., Sar S., Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. Res. Commun. 177: 679, 1991.

    Article  PubMed  CAS  Google Scholar 

  22. Sciacchitano S., Paliotta D.S., Nardi F., Sacchi A., Andreoli M., Pontecorvi A. PCR amplification and analysis of ras oncogene from thyroid cytologic smears. Diagn. Mol. Pathol. 3: 114, 1994

    Article  PubMed  CAS  Google Scholar 

  23. Matsuo K., Friedman E., Gejman P.V., Fagin J.A. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the α-subunit of Gs in human thyroid neoplasms. J. Clin. Endocrinol. Metab. 76: 1446, 1993.

    PubMed  CAS  Google Scholar 

  24. Russo D., Arturi F., Wicker R., Chazenbalk G.D., Schlumberger M., DuVillard J.A.D., Caillou B., Monier R., Rapoport B., Filetti S. Genetic alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol. Metab. 80: 1347, 1995.

    PubMed  CAS  Google Scholar 

  25. Porcellini A., Ciullo I., Laviola L., Amabile G., Fenzi G., Avvedimento V.E. Novel mutations of thyrotropin receptor in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J. Clin. Endocrinol. Metab. 79: 657, 1994.

    PubMed  CAS  Google Scholar 

  26. Van Sande J., Parma J., Tonacchera M., Swillens S., Dumont J.E., Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J. Clin. Endocrinol. Metab. 80: 2577, 1995.

    PubMed  Google Scholar 

  27. Strader C.D., Fong T.M., Tota M.R., Underwood D. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63: 101, 1994.

    Article  PubMed  CAS  Google Scholar 

  28. Lyons J., Landis C.A., Harsh G., Vallar L., Grunewald K., Feichtinger H., Duh QY., Clark O.H., Kawasaki E., Bourne H.R., McCormick F. Two G protein oncogenes in human endocrine tumors. Science 249: 655, 1990.

    Article  PubMed  CAS  Google Scholar 

  29. O’Sullivan C., Barton C.M., Staddon S.L., Brown C.L., Lemoine N.R. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol. Carcinogen. 4: 345, 1991.

    Article  Google Scholar 

  30. Saïd S., Schlumberger M., Suarez H.G. Oncogenes and anti-oncogenes in human epithelial thyroid tumors. J. Endocrinol. Invest. 17: 37, 1994.

    Article  Google Scholar 

  31. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy G., Mockel J., Dumont J.E., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649, 1993.

    Article  PubMed  CAS  Google Scholar 

  32. Paschke R., Tonacchera M., Van Sande J., Parma J., Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J. Clin. Endocrinol. Metab. 79: 1785, 1994.

    PubMed  CAS  Google Scholar 

  33. Takeshita A., Nagayama Y., Yokoyama N., Ishikawa N., Ito K., Yamashita T., Obara T., Murakami Y., Kuma K., Takamatsu J., Ohsawa N., Nagataki S. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J. Clin. Endocrinol. Metab. 80: 2607, 1995.

    PubMed  CAS  Google Scholar 

  34. Parma J., Van Sande J., Swillens S., Tonacchera M., Dumont J.E., Vassart G. Somatic mutations causing constitutive activity of the Thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Mol. Endocrinol. 9: 725, 1995.

    PubMed  CAS  Google Scholar 

  35. Russo D., Arturi F., Suarez H.G., Schlumberger M., DuVillard J.A.D., Crocetti U., Filetti S. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J. Clin. Endocrinol. Metab. 81: 1548, 1996.

    PubMed  CAS  Google Scholar 

  36. Duprez L., Parma J., Dumont J.E., Hermans J., Vassart G. Diversity and prevalence of somatic mutations in the TSH receptor gene as a cause of toxic adenoma. J. Endocrinol. Invest. 19(Suppl. 6): 69, 1996. (Abstract).

    Google Scholar 

  37. Michiels F., Caillou B., Talbot M., Dessarps-Freichey F., Maunaury M., Schlumberger M., Merken L., Monier R. Oncogenic potential of guanine nucleotide stimulatory factor a subunit in thyroid gland of transgenic mice. Proc. Natl. Acad. Sci. USA 91: 10488, 1994.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  38. Morris J.C. Editorial: Activating mutations of the thyrotropin receptor — Unanswered questions. J. Clin. Endocrinol. Metab. 81: 2021, 1996.

    Article  PubMed  CAS  Google Scholar 

  39. Derwahl M. Editorial: TSH receptor and Gs-α gene mutations in the pathogenesis of toxic thyroid adenomas — A note of caution. J. Clin. Endocrinol. Metab. 81: 2783, 1996.

    PubMed  CAS  Google Scholar 

  40. Hamburger J.I. The autonomously functioning thyroid nodule: Goetsch’s disease. Endocr. Rev. 8: 439, 1987.

    Article  PubMed  CAS  Google Scholar 

  41. Belfiore A., Sava L., Runello F., Tomaselli L., Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J. Clin. Endocrinol. Metab. 56: 283, 1983.

    Article  PubMed  CAS  Google Scholar 

  42. Chiovato L., Santini F., Pinchera A. Treatment of hyperthyroidism In: Hennemann G., Krenning E. (Eds.), Thyroid International. E. Merck, Darmstadt, 1995, Vol. 2, p. 18.

    Google Scholar 

  43. Duprez L., Parma J., Van Sande J., Allgeier A., Leclere J., Schvartz C., Delisle MJ., Decoulx M., Orgiazzi J., Dumont J.E., Vassart G. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat. Genet. 7: 396, 1994.

    Article  PubMed  CAS  Google Scholar 

  44. Tonacchera M., Van Sande J., Cetani F., Swillens S., Schvartz C., Winiszewski P., Portmann L., Dumont J.E., Vassart G., Parma J. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J. Clin. Endocrinol. Metab. 81: 547, 1996.

    PubMed  CAS  Google Scholar 

  45. Kohler B., Biebermann H., Krohn H.P., Dralle D., Finke R., Gruters A. A novel germline mutation in the thyrotropin receptor (TSHR) gene causing nonautoimmune congenital hyperthyroidism. 10th International Congress of Endocrinology, San Francisco, USA. P2–946, 1996, (Abstract).

  46. Kopp P., Van Sande J., Parma J., Duprez L., Gerber H., Joss E., Jameson J.L., Dumont J.E., Vassart G. Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N. Engl. J. Med. 332: 150, 1995.

    Article  PubMed  CAS  Google Scholar 

  47. De Roux N., Polak M., Couet J., Leger J., Czernikow P., Milgrom E., Misrahi M. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J. Clin. Endocrinol. Metab. 81: 2023, 1996.

    PubMed  Google Scholar 

  48. Holzapfel H.P., Wonerow P., Henshen M., Petrykowski W., Scherbaum W.A., Paschke R. Congenital nonautoimmune hyperthyroidism caused by a new sporadic germline mutation in the thyrotropin receptor gene. J. Endocrinol. Invest. 19(Suppl. 6): 25, 1996. (Abstract).

    Google Scholar 

  49. Esapa C.T., Betts P., Kendall-Taylor P., Harris P.E. A novel TSH receptor mutation in an infant with thyrotoxicosis. J. Endocrinol. Invest. 19(Suppl. 6): 71, 1996. (Abstract).

    Google Scholar 

  50. Derwahl M., Hamacher C., Russo D., Broecker M., Manole D., Schatz H., Kopp P., Filetti S. Constitutive activation of the Gs-α protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J. Clin. Endocrinol. Metab. 81: 1898, 1996.

    PubMed  CAS  Google Scholar 

  51. Sunthornthepvarakul T., Gottschalk M.E., Hayashi Y., Refetoff S. Brief report: Resistance to thyrotropin caused by mutation in the thyrotropin receptor gene. N. Engl. J. Med. 332: 155, 1995.

    Article  CAS  Google Scholar 

  52. Asteria C., Persani L., Romoli R., Beck-Peccoz P. Resistance to thyrotropin action resulting from inactivating mutation of thyrotropin receptor (TSH-R) gene. J. Endocrinol. Invest. 19(Suppl. 6). 26, 1996. (Abstract).

    Google Scholar 

  53. Biebermann H., Krude H., Thiede C., Kotulla P., Gruters A. Sporadic congenital hypothyroidism due to compound heterozygosity for two mutations of the coding sequence of the thyrotropin receptor gene. 10th International Congress of Endocrinology, San Francisco, USA. P2–954, 1996 (Abstract).

  54. Clifton-Bligh R., Gregory J.W., John R., Chatterjee V.K.K. Resistance to thyrotropin caused by two novel mutations in the TSH receptor gene. J. Endocrinol. Invest. 19(Suppl. 6): 68, 1996. (Abstract).

    Google Scholar 

  55. Takeshita A., Nagayama Y., Yamashita S., Takamatsu J., Ohsawa N., Maesaka H, Tachibana K., Tokuhiro E., Ashizawa K., Yokoyama N., Nagataki S. Sequence analysis of the thyrotropin (TSH) receptor gene in congenital primary hypothyroidism associated with TSH unresponsiveness. Thyroid 4: 255, 1994.

    Article  PubMed  CAS  Google Scholar 

  56. Bohr U. R. M., Behr M., Loos U. A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves’ immunoglobulins. Biochim. Biophys. Acta 1216: 504, 1993.

    Article  PubMed  CAS  Google Scholar 

  57. Bahn R.S., Dutton C.M., Heufelder A.E., Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 78: 256, 1994.

    PubMed  CAS  Google Scholar 

  58. Sunthornthepvarakul T., Hayasahi Y., Refetoff S. Polymorphism of a variant human thyrotropin receptor (hTSHR) gene. Thyroid 4: 147, 1994.

    Article  PubMed  CAS  Google Scholar 

  59. Cuddihy R.M., Dutton C.M., Bahn R.S. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5: 89, 1995.

    Article  PubMed  CAS  Google Scholar 

  60. Watson P.F., French A., Pickerill P., Mcintosh S., Weetman A.P. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves’ disease. J. Clin. Endocrinol. Metab. 80: 1032, 1995.

    PubMed  CAS  Google Scholar 

  61. Heufelder A.E. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves’ ophthalmopathy. Thyroid 5: 331, 1995.

    Article  PubMed  CAS  Google Scholar 

  62. Wu S.-L., Chang T.-J., Chang T.-J., Kuo Y.-F., Hsiao Y.-L., Chang C.-C. Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J. Endocrinol. Invest. 19: 365, 1996.

    Article  PubMed  CAS  Google Scholar 

  63. Paschke R., Vassart G., Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathy. Clin. Endocrinol. 42: 565, 1995.

    Article  CAS  Google Scholar 

  64. De Roux N., Shields D.C., Misrahi M., Ratanachaiyavong S., McGregor A.M., Milgrom E. Analysis of the tyrotropin receptor as a candidate gene in familial Graves’ disease. J. Clin. Endocrinol. Metab. 81: 3483, 1996.

    PubMed  Google Scholar 

  65. Powis G. Signalling pathways as targets for anticancer drug development. Pharmacol. Ther. 62: 57, 1994

    Article  PubMed  CAS  Google Scholar 

  66. Wynford-Thomas D. Molecular genetics of thyroid cancer. Curr. Opin. Endocrinol. Diab. 2: 429, 1995.

    Article  CAS  Google Scholar 

  67. Suarez H.G., duVillard J.A., Caillou B., Schlumberger M., Parmentier C., Monier R. GSP mutations in human thyroid tumours. Oncogene 6: 677, 1991.

    PubMed  CAS  Google Scholar 

  68. Yoshimoto K., Iwahana H., Fukuda A., Sano T., Itakura M. Rare mutations of the Gs alpha subunit in human endocrine tumors. Cancer 72: 1386, 1993.

    Article  PubMed  CAS  Google Scholar 

  69. Horie H., Yokogoshi Y., Tsuyuguchi M., Saito S. Point mutations of ras and Gsα subunit genes in thyroid tumors. Jpn. J. Cancer Res. 86: 737, 1995.

    Article  PubMed  CAS  Google Scholar 

  70. Russo D., Arturi F., Schlumberger M., Caillou B., Monier R., Filetti S., Suarez H.G. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11: 1907, 1995.

    PubMed  CAS  Google Scholar 

  71. Ohno M., Endo T., Ohta K, Gunji K., Onaya T. Point mutations in the thyrotropin receptor in human thyroid tumors. Thyroid 5: 97, 1995.

    Article  PubMed  CAS  Google Scholar 

  72. Russo D., Belfiore A., Tumino S., Arturi F., Pontecorvi A., Chiefari E., Grasso G., Pezzino V., Filetti S. A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor. J. Endocrinol. Invest. 19(Suppl. 6): 71, 1996. (Abstract).

    Google Scholar 

  73. Uyttersprot N., Van Sande J., Dumont J.E. Editorial: Thyroid adenoma, Gsα expression and the cyclic adenosine monophosphate mitogenic cascade: a complex relationship. J. Clin. Endocrinol. Metab. 88: 1518, 1995.

    Google Scholar 

  74. Porcellini A., Tassi V., Ciullo I., Pannain S., Amabile G., Cisternino C., Di Cerbo A., Papini E., Avvedimento V.E., Fenzi G. Studies on the prevalence of TSH receptor mutations in a large series of consecutive hyperfunctioning thyroid adenomas. Thyroid 5(Suppl. 1): S–8, 1995. (Abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Farmacologia, Facoltà di Medicina e Chirurgia e di Farmacia, Cattedra di Endocrinologia Catanzaro University of Reggio Calabria, Reggio Calabria, Italy

    D. Russo

  2. Dipartimento di Medicina Sperimentale e Clinica, Cattedra di Endocrinologia, Catanzaro University of Reggio Calabria, Reggio Calabria, Italy

    F. Arturi, E. Chiefari & Sebastiano Filetti M.D.

Authors
  1. D. Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Arturi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Chiefari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sebastiano Filetti M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russo, D., Arturi, F., Chiefari, E. et al. Molecular insights into TSH receptor abnormality and thyroid disease. J Endocrinol Invest 20, 36–47 (1997). https://doi.org/10.1007/BF03347971

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347971

Key-words

Search

Navigation